Table of Contents
International Journal of Molecular Imaging
Volume 2014, Article ID 507012, 10 pages
http://dx.doi.org/10.1155/2014/507012
Research Article

Ex Vivo Characterization of a Novel Iodine-123-Labelled Aminomethylchroman as a Potential Agonist Ligand for SPECT Imaging of Dopamine D2/3 Receptors

1Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands
2SyMO-Chem BV, Den Dolech 2, 5612 AZ Eindhoven, Netherlands
3GE Healthcare, De Rondom 8, 5612 AP Eindhoven, Netherlands
4Department of Pharmacology, Johannes Gutenberg University, Obere Zahlbacher Straße 67, 55101 Mainz, Germany
5Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, Netherlands

Received 29 July 2014; Revised 18 November 2014; Accepted 27 November 2014; Published 25 December 2014

Academic Editor: Adriaan A. Lammertsma

Copyright © 2014 Jan-Peter van Wieringen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jan-Peter van Wieringen, Kora de Bruin, Henk M. Janssen, et al., “Ex Vivo Characterization of a Novel Iodine-123-Labelled Aminomethylchroman as a Potential Agonist Ligand for SPECT Imaging of Dopamine D2/3 Receptors,” International Journal of Molecular Imaging, vol. 2014, Article ID 507012, 10 pages, 2014. https://doi.org/10.1155/2014/507012.